Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
85.35
+1.26 (1.50%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Haemonetics Income Statement

Millions USD. Fiscal year is May - Apr.
Year 2022202120202019201820172016201520142013 2012 - 1994
Revenue
1,169993.2870.46988.48967.58903.92886.12908.83910.37938.51
Upgrade
Revenue Growth (YoY)
17.67%14.10%-11.94%2.16%7.04%2.01%-2.50%-0.17%-3.00%5.22%
Upgrade
Cost of Revenue
553.56487.69472.63503.97550.04492.02507.62502.92475.96470.14
Upgrade
Gross Profit
615.1505.5397.84484.51417.54411.91378.49405.91434.42468.37
Upgrade
Selling, General & Admin
376.68340.14275.22282.02273.47316.52301.73317.22337.17365.98
Upgrade
Research & Development
50.1346.832.8630.8835.7139.2337.5644.9754.1954.2
Upgrade
Other Operating Expenses
32.2637.810.0268.2624.8058.5987.672.521.76
Upgrade
Operating Expenses
459.06424.75308.09381.16333.99355.75397.88449.86393.88421.93
Upgrade
Operating Income
156.0380.7589.75103.3583.5556.16-19.38-43.9440.5446.43
Upgrade
Interest Expense / Income
14.6317.1216.8316.29.914.538.19.4700
Upgrade
Other Expense / Income
------8--9.3810.03
Upgrade
Pretax Income
141.463.6372.9187.1573.6359.63-27.48-53.4231.1736.4
Upgrade
Income Tax
2620.25-6.5610.6318.6114.06-1.212.1614.271.25
Upgrade
Net Income
115.443.3879.4776.5355.0245.57-26.27-55.5816.935.15
Upgrade
Net Income Growth
166.05%-45.42%3.85%39.09%20.73%----51.93%-9.41%
Upgrade
Shares Outstanding (Basic)
51515151525352515252
Upgrade
Shares Outstanding (Diluted)
51515152535452515252
Upgrade
Shares Change
0.13%0.12%-1.01%-2.13%-1.04%3.84%1.21%-2.26%-0.55%0.23%
Upgrade
EPS (Basic)
2.270.851.571.511.070.86-0.51-1.090.330.68
Upgrade
EPS (Diluted)
2.240.841.551.481.040.85-0.51-1.090.320.67
Upgrade
EPS Growth
166.67%-45.81%4.73%42.31%22.35%----52.24%-9.46%
Upgrade
Free Cash Flow
164.4877.7873.58126.2343.13148.3186.4320.15.4166.36
Upgrade
Free Cash Flow Per Share
3.241.521.452.490.842.811.680.400.101.29
Upgrade
Gross Margin
52.63%50.90%45.70%49.02%43.15%45.57%42.71%44.66%47.72%49.91%
Upgrade
Operating Margin
13.35%8.13%10.31%10.46%8.63%6.21%-2.19%-4.83%4.45%4.95%
Upgrade
Profit Margin
9.87%4.37%9.13%7.74%5.69%5.04%-2.96%-6.12%1.86%3.75%
Upgrade
Free Cash Flow Margin
14.07%7.83%8.45%12.77%4.46%16.41%9.75%2.21%0.59%7.07%
Upgrade
Effective Tax Rate
18.39%31.83%-8.99%12.19%25.28%23.58%--45.78%3.44%
Upgrade
EBITDA
249.34178.5174.03213.64192.96153.470.3545.97117.22118.14
Upgrade
EBITDA Margin
21.34%17.97%19.99%21.61%19.94%16.97%7.94%5.06%12.88%12.59%
Upgrade
Depreciation & Amortization
93.3197.7584.29110.29109.4289.2589.7389.9186.0581.74
Upgrade
EBIT
156.0380.7589.75103.3583.5564.16-19.38-43.9431.1736.4
Upgrade
EBIT Margin
13.35%8.13%10.31%10.46%8.63%7.10%-2.19%-4.83%3.42%3.88%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).